Abstract:A previously healthy 1-year-old boy presented to the Department of Respiratory Medicine with a 10-day history of cough, wheeze, and fever. Despite therapy with antibiotics (cefaclor, 30 mg/kg/d orally, divided into 3 doses) and bronchodilators (procaterol hydrochloride, 2 μg/kg/d, twice daily) for 7 consecutive days at the local primary health care facility, the child's respiratory status progressively deteriorated and he was referred to our institution. A chest radiograph revealed bilateral patchy consolidation. Streptococcus pneumoniae urinary antigen was positive. Intravenous amoxicillin-clauvulanic acid, inhaled corticosteroids and bronchodilators, and oral mucolytics were administered for a working diagnosis of community-acquired pneumonia. On the second day of hospitalization, the patient developed an irregular macular rash on the face, neck, and trunk. Beta-lactam antibiotic allergy was suspected. Cetirizine hydrochloride was administered and the antibiotic was replaced with meropenem. In the following 3 days the rash transformed into a confluent maculopapular exanthema with blisters and denudation of the epidermis in large patches that involved large areas (roughly 90%) of the body surface (Figure 1, A and B). Multiple erosive lesions developed on the oropharyngeal, anal, and ocular mucosa. In addition, he was febrile and dyspneic. Toxic epidermal necrolysis (TEN) was confirmed and the child was transferred to the pediatric intensive care unit for hypoxemia. In addition to noninvasive ventilation and supportive systemic therapy, he was treated with intravenous methylprednisolone and gamma globulin, plasmapheresis, surgical wound care, and ophthalmic lubricant. Acinetobacter baumannii and Klebsiella pneumoniae were isolated from wound swab cultures and the antibiotic treatment was changed to intravenous tigecycline and polymyxin. During the hospitalization period, fluid balance and creatinine remained stable. The patient's SCORe of Toxic Epidermal Necrosis was 2 (mild) (body surface area involved > 10%, score 1; tachycardia > 120 bpm, score 1).1Bastuji-Garin S. Fouchard N. Bertocchi M. Roujeau J.C. Revuz J. Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.J Invest Dermatol. 2000; 115: 149-153Abstract Full Text Full Text PDF PubMed Scopus (802) Google Scholar The skin reepithelialized progressively (Figure 1, C and D) and the patient was discharged after a 14-week stay. TEN is a potentially life-threatening disorder characterized by widespread epidermal necrosis of skin and mucosa involving greater than 30% of the body surface area.2Alerhand S. Cassella C. Koyfman A. Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review.Pediatr Emerg Care. 2016; 32: 472-476Crossref PubMed Scopus (26) Google Scholar Although the precise pathogenic mechanism is not understood, cutaneous reactions in TEN lead to keratinocyte apoptosis, which may be induced by drugs or infections or be idiopathic. Medications are the most common reported cause. The culprit antibiotic causing TEN in this patient is not certain, because both cephalosporins and beta-lactamase inhibitors may be etiological factors. TEN usually develops between 4 and 28 days after drug intake; however, in rare cases of rechallenge with a drug with similar structure, the disease appears more rapidly, within hours. This might suggest that the TEN developed in response to coamoxiclav, although the immune-related cytotoxic reaction could have been initiated during the initial antibiotic treatment with cefaclor. The management of TEN is challenging, involving a wide array of costly resources, prolonged hospital stays, and potential mortality.2Alerhand S. Cassella C. Koyfman A. Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: a review.Pediatr Emerg Care. 2016; 32: 472-476Crossref PubMed Scopus (26) Google Scholar The outcomes depend on prompt discontinuation of the suspected causative drug, antimicrobial treatment, wound care, and supportive therapies.

Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults

Comparison of incidence, causes and prognosis of adult and paediatric epidermal necrolysis: a French population-based study

Outcome measurements in epidermal necrolysis: a systematic review

P077 Toxic Epidermal Necrolysis-Optimal Management (TEN-OM): a retrospective cohort analysis from two centres

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages

S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy

Toxic epidermal necrolysis: management strategies in burns units

Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management

Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases

Systematic review and meta‐analysis of non‐SCORTEN predictors of mortality in Stevens‐Johnson syndrome and toxic epidermal necrolysis

Infectious complications of Stevens‐Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta‐analysis

Candidaemia and Candida colonization in patients with epidermal necrolysis: a retrospective case series

Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results

Management of severe toxic epidermal necrolysis in children

Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020

Toxic Epidermal Necrolysis in a Child

Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database

Retrospective Study of 213 Cases of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis from China.

Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review

Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients